{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T22:08:13Z","timestamp":1789250893105,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20211075"],"award-info":[{"award-number":["BK20211075"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007824","name":"Soochow University","doi-asserted-by":"publisher","award":["H230028"],"award-info":[{"award-number":["H230028"]}],"id":[{"id":"10.13039\/501100007824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82,371,365"],"award-info":[{"award-number":["82,371,365"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471358"],"award-info":[{"award-number":["82471358"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.cca.2026.121327","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:46:19Z","timestamp":1788619579000},"page":"121327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluation of the predictive value of sCD200 and sCD200R for disease severity and relapse in myasthenia gravis"],"prefix":"10.1016","volume":"594","author":[{"given":"Yajie","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzheng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingluan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2026.121327_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2025.1728767","article-title":"Alterations in plasma cytokine profiles in generalized myasthenia gravis following different immunotherapeutic regimens","volume":"16","author":"Ren","year":"2025","journal-title":"Front. Neurol."},{"key":"10.1016\/j.cca.2026.121327_bb0010","article-title":"Serum cytokine profiles in patients with myasthenia gravis","volume":"16","author":"Wu","year":"2025","journal-title":"Front. Neurol."},{"key":"10.1016\/j.cca.2026.121327_bb0015","doi-asserted-by":"crossref","DOI":"10.1177\/17562864251319656","article-title":"Patterns and predictors of therapeutic response to efgartigimod in acetylcholine receptor-antibody generalized myasthenia gravis subtypes","volume":"18","author":"Jin","year":"2025","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.cca.2026.121327_bb0020","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-026-07925-5","article-title":"Efficacy and safety of immunosuppressants and immunomodulators in juvenile myasthenia gravis: a systematic review and meta-analysis","volume":"24","author":"Zhong","year":"2026","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cca.2026.121327_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2026.1780647","article-title":"Low-dose versus standard-dose intravenous immunoglobulin in generalized myasthenia gravis: a prospective single-center cohort study","volume":"17","author":"Luo","year":"2026","journal-title":"Front. Neurol."},{"key":"10.1016\/j.cca.2026.121327_bb0030","article-title":"Double-filtration plasmapheresis versus efgartigimod for generalized myasthenia gravis: severity-stratified benefits in a prospective observational multicenter study","volume":"32","author":"Wang","year":"2026","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.cca.2026.121327_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1645460","article-title":"Bone marrow mesenchymal stem cells alleviate smoke inhalation injury by regulating alveolar macrophage polarization via the CD200-CD200R pathway","volume":"16","author":"Ding","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.121327_bb0040","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41423-024-01136-y","article-title":"CD200Rhigh neutrophils with dysfunctional autophagy establish systemic immunosuppression by increasing regulatory T cells","volume":"21","author":"Kim","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cca.2026.121327_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1882","article-title":"CD200-CD200R1 signaling pathway regulates neuroinflammation after stroke","volume":"10","author":"Zhao","year":"2020","journal-title":"Brain Behav."},{"key":"10.1016\/j.cca.2026.121327_bb0050","article-title":"Antigens activated SOCS3+CD200R+CD4+ T cells are critical to Leishmania pathogenesis and a distinctive target for vaccine development","volume":"62","author":"Singh","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.cca.2026.121327_bb0055","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00018-024-05268-2","article-title":"CD200R activation on na\u00efve T cells by B cells induces suppressive activity of T cells via IL-24","volume":"81","author":"Chu","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cca.2026.121327_bb0060","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s00262-024-03678-6","article-title":"CD200 is overexpressed in the pancreatic tumor microenvironment and predictive of overall survival","volume":"73","author":"Wedig","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cca.2026.121327_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103278","article-title":"Soluble form of immune checkpoints in autoimmune diseases","volume":"147","author":"Yuan","year":"2024","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cca.2026.121327_bb0070","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0378-1119(03)00562-6","article-title":"Characterization of human cd200 glycoprotein receptor gene located on chromosome 3q12-13","volume":"311","author":"Vieites","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.cca.2026.121327_bb0075","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/1756-185X.13810","article-title":"Increased CD200 levels in peripheral blood mononuclear cells of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"23","author":"Liu","year":"2020","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.cca.2026.121327_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14082720","article-title":"Clinical utility of serum sCD200\/sCD200R ratios in predicting current activity of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"14","author":"Ha","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cca.2026.121327_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262311371","article-title":"Immune checkpoint signatures in minimal change disease and membranous nephropathy: divergent pathways of a shared imbalance","volume":"26","author":"Mertowski","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2026.121327_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.648","article-title":"Reduced cutaneous CD200:CD200R1 signaling in psoriasis enhances neutrophil recruitment to skin","volume":"10","author":"Linley","year":"2022","journal-title":"Immunity, Inflammation and Disease."},{"key":"10.1016\/j.cca.2026.121327_bb0095","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-026-03782-1","article-title":"Increased soluble CD200 in serum of SLE patients does not reflect disease activity or affect CD200R1 function in T cells","volume":"28","author":"Kaan","year":"2026","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cca.2026.121327_bb0100","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3390\/cells14191551","article-title":"Checkpoint imbalance in primary Glomerulopathies: comparative insights into IgA nephropathy and Membranoproliferative glomerulonephritis","volume":"14","author":"Mertowski","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.cca.2026.121327_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2025.111686","article-title":"Peripheral CD200R signaling: a critical regulator of post-stroke inflammation in aged mice","volume":"234","author":"Ngwa","year":"2026","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.cca.2026.121327_bb0110","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.3390\/biomedicines11123326","article-title":"CD200\/CD200R: bidirectional role in Cancer progression and immunotherapy","volume":"11","author":"Nip","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.cca.2026.121327_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1608160","article-title":"Subtype-specific atypical B cell profiles in myasthenia gravis reveal distinct immunopathological pathways","volume":"16","author":"Sikorski","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.121327_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2024.578441","article-title":"Conventional dendritic cells are more activated in the hyperplastic Thymus of myasthenia gravis patients","volume":"395","author":"Chen","year":"2024","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cca.2026.121327_bb0125","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jocn.2022.10.017","article-title":"Correlation between neutrophil-to-lymphocyte ratio and severity of myasthenia gravis in adults: a retrospective study","volume":"106","author":"Duan","year":"2022","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.cca.2026.121327_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2025.110634","article-title":"IMPDH2 facilitates CD4+ T cell activation through AKT\/mTOR pathway by upregulating SRPK1 in myasthenia gravis","volume":"282","author":"Ren","year":"2026","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cca.2026.121327_bb0135","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150750","article-title":"CD200 ectodomain shedding into the tumor microenvironment leads to NK cell dysfunction and apoptosis","volume":"132","author":"Morgan","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2026.121327_bb0140","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jneuroim.2007.10.018","article-title":"Serum matrix metalloproteinase-3 levels are elevated in myasthenia gravis","volume":"195","author":"Romi","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cca.2026.121327_bb0145","article-title":"Matrix metalloproteinase-3 in myasthenia gravis compared to other neurological disorders and healthy controls","volume":"2011","author":"Luckman","year":"2011","journal-title":"Autoimmune Dis."},{"key":"10.1016\/j.cca.2026.121327_bb0150","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1023\/B:NEUR.0000021907.68461.9c","article-title":"Structural alterations at the neuromuscular junctions of matrix metalloproteinase 3 null mutant mice","volume":"32","author":"VanSaun","year":"2003","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.cca.2026.121327_bb0155","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1084\/jem.170.6.2081","article-title":"Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones","volume":"170","author":"Fiorentino","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cca.2026.121327_bb0160","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-065X.2008.00706.x","article-title":"Interleukin-10: new perspectives on an old cytokine","volume":"226","author":"Mosser","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cca.2026.121327_bb0165","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1182\/blood-2014-09-599159","article-title":"CD24(hi)CD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease","volume":"125","author":"de Masson","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.cca.2026.121327_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2022.152315","article-title":"Monocyte-derived immature dendritic cells negatively regulate hepatic stellate cells in vitro by secreting IL-10","volume":"228","author":"Xu","year":"2023","journal-title":"Immunobiology"},{"key":"10.1016\/j.cca.2026.121327_bb0175","article-title":"Autoreactive T cells and thymic atrophy pathway in thymic hyperplasia patients with myasthenia gravis","volume":"17","author":"Wang","year":"2026","journal-title":"Front. Neurol."},{"key":"10.1016\/j.cca.2026.121327_bb0180","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jneuroim.2004.04.021","article-title":"Dendritic cells activate autologous T cells and induce IL-4 and IL-10 production in myasthenia gravis","volume":"156","author":"Adikari","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cca.2026.121327_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2026.153192","article-title":"The alterations of blood immune subpopulations, cytokines, and metabolites in anti-acetylcholine receptor antibody-positive myasthenia gravis: a real-world, observational, high-throughput study","volume":"231","author":"Meng","year":"2026","journal-title":"Immunobiology"},{"key":"10.1016\/j.cca.2026.121327_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/eji.70166","article-title":"Selective depletion of autoreactive plasma cells as a novel strategy to treat acetylcholine receptor antibody-positive myasthenia gravis","volume":"56","author":"Khodadadi","year":"2026","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cca.2026.121327_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2025.578621","article-title":"Elevated serum levels of IL-10 family and IL-12 family cytokines in myasthenia gravis","volume":"404","author":"Onishi","year":"2025","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cca.2026.121327_bb0200","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1159\/000510396","article-title":"Therapeutic and Immunoregulatory effects of tacrolimus in patients with refractory generalized myasthenia gravis","volume":"83","author":"Wu","year":"2020","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.cca.2026.121327_bb0205","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2026-002068","article-title":"Integrated immune profiling identifies a coordinated T-cell activation and inflammatory signature in SLE","volume":"13","author":"Lisowska","year":"2026","journal-title":"Lupus Sci Med."},{"key":"10.1016\/j.cca.2026.121327_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.986199","article-title":"Changes in peripheral T-lymphocyte subsets and serum cytokines in patients with systemic sclerosis","volume":"13","author":"Guo","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cca.2026.121327_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110565","article-title":"CD4+ T-cell-derived IL-10 promotes CNS inflammation in mice by sustaining effector T cell survival","volume":"38","author":"Yogev","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.cca.2026.121327_bb0220","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/s41423-023-01079-w","article-title":"B-cell-derived IL-10 promotes allergic sensitization in asthma regulated by Bcl-3","volume":"20","author":"Qian","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cca.2026.121327_bb0225","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adu3624","article-title":"Antigen-specific B cell response regulation by IL-10\u2013producing tolerogenic dendritic cells","volume":"11","author":"Morali","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cca.2026.121327_bb0230","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1007\/s12035-025-04744-5","article-title":"Serum inflammatory factors levels and risk of myasthenia gravis: a bidirectional Mendelian randomization study","volume":"62","author":"Jingjing","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.cca.2026.121327_bb0235","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.molimm.2022.02.019","article-title":"CD200R family receptors are expressed on porcine monocytes and modulate the production of IL-8 and TNF-\u03b1 triggered by TLR4 or TLR7 in these cells","volume":"144","author":"Poderoso","year":"2022","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cca.2026.121327_bb0240","doi-asserted-by":"crossref","first-page":"824","DOI":"10.14336\/AD.2023.0528","article-title":"Responsiveness to tocilizumab in anti-acetylcholine receptor-positive generalized myasthenia gravis","volume":"15","author":"Jia","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.cca.2026.121327_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577634","article-title":"High levels of serum interleukin-6 are associated with disease activity in myasthenia gravis","volume":"358","author":"Uzawa","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cca.2026.121327_bb0250","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s13023-024-03466-6","article-title":"Nomogram for predicting pregnancy-related relapse of myasthenia gravis","volume":"19","author":"Su","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.cca.2026.121327_bb0255","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.18562","article-title":"Nonlinear relationship between circulating natural killer cell count and 1-year relapse rates in myasthenia gravis: a retrospective cohort study","volume":"12","author":"Zhang","year":"2024","journal-title":"PeerJ"},{"key":"10.1016\/j.cca.2026.121327_bb0260","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1080\/01616412.2024.2340883","article-title":"Serum globulin in children with myasthenia gravis: predicting relapse and prognosis","volume":"46","author":"Jiang","year":"2024","journal-title":"Neurol. Res."},{"key":"10.1016\/j.cca.2026.121327_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156485","article-title":"Macrophage migration inhibitory factor: a noval biomarker upregulates in myasthenia gravis and correlates with disease severity and relapse","volume":"175","author":"Huang","year":"2024","journal-title":"Cytokine"},{"key":"10.1016\/j.cca.2026.121327_bb0270","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1158\/2767-9764.CRC-24-0568","article-title":"First-in-human study of 23ME-00610, an antagonistic antibody for genetically validated CD200R1 immune checkpoint, in participants with advanced solid malignancies","volume":"5","author":"Kummar","year":"2025","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.cca.2026.121327_bb0275","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s40425-019-0710-1","article-title":"Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200","volume":"7","author":"Mahadevan","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.cca.2026.121327_bb0280","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1038\/s41467-025-59147-w","article-title":"Ucenprubart is an agonistic antibody to CD200R with the potential to treat inflammatory skin disease: preclinical development and a phase 1 clinical study","volume":"16","author":"Koester","year":"2025","journal-title":"Nat. Commun."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126005097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126005097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T21:48:28Z","timestamp":1789249708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126005097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":56,"alternative-id":["S0009898126005097"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121327","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the predictive value of sCD200 and sCD200R for disease severity and relapse in myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121327"}}